Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil

Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil

Sarcopenia is common in metastatic colorectal cancer (mCRC), increases the risk of treatment-related toxicity and reduces survival. Trifluridine/tipiracil (TT) chemotherapy significantly improved survival in refractory mCRC patients, but the prognostic and predictive role of pretherapeutic sarcopeni...

Full description

Saved in:
Bibliographic Details
Main Authors: Mateusz Malik, Maciej Michalak, Barbara Radecka, Marek Gełej, Aleksandra Jackowska, Emilia Filipczyk-Cisarż, Katarzyna Hetman, Małgorzata Foszczyńska-Kłoda, Beata Kania-Zembaczyńska, Danuta Mańka, Marlena Orlikowska, Hanna Rogowska-Droś, Lubomir Bodnar
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
sarcopenia
metastatic colorectal cancer
cancer cachexia
trifluridine/tipiracil
Medicine
R
Online Access:https://doaj.org/article/a4d0d1c41af74f5a98c83cefe33c0f6c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/a4d0d1c41af74f5a98c83cefe33c0f6c

Similar Items